Request a Quote

In Vivo Teratoma Development Services

In Vivo Teratoma Development Services
Teratoma is created via the injection of a customer’s ES or iPS cells – two vials of ES/iPS cells (approximately 1,000,000 cells/ vial) are received from the customer. Cells must be tested by the customer to ensure that the cells are pathogen-free. The customer is also required to provide information related to genetic modifications, including the modification method details (e.g., retrovirus). We provide information about the number of injection/inoculation sites as well as the growth of teratoma/tumor. Company scientists can provide additional information and/or fulfill specific marker staining requests as additional services.

To find out more details about this custom service, Please request a quote today.